Statistics for Long-term results of brentuximab vedotin in relapsed and refractory Hodgkin lymphoma: Multi-center real-life experience

Total visits

views
Long-term results of brentuximab vedotin in relapsed and refractory Hodgkin lymphoma: Multi-center real-life experience 1

Total visits per month

views
May 2024 0
June 2024 0
July 2024 0
August 2024 0
September 2024 0
October 2024 0
November 2024 0